An advisory panel of the U.S. Food and Drug Administration (FDA) voted to recommend Opill be sold over the counter (OTC) without a prescription. Opill is a hormonal contraceptive pill first approved in 1970. Advisory committees are panels of outside medical experts who advise the FDA on matters related to the specific area they were appointed to. There are numerous advisory panels. In the latest vote, one panel advises on over-the-counter medications. Another panel advises on reproductive health. The combined panel was composed of 17 experts in a 2-day hearing.
Search Results for: hearing
Thursday Links
- Why we need Association Health Plans for small businesses and gig workers: Less than one-third of small companies are even offering heath insurance to their employees.
- Why doctors so aggressively pushed the Covid vaccines.
- Sanders/Cassidy bill would speed genic drugs to the marketplace.
- Mattel is making a Barbie doll with Down syndrome: “It’s set to join existing dolls with behind-the-ear hearing aids, a wheelchair, alopecia and a prosthetic limb within the company’s heavily diversity and inclusion-focused line.”
- Against bringing back the Woolly mammoth.
- An early estimate of the cost of Covid from Harvard: $16 trillion!
Friday Links
- Antos: Against Medicare coverage for hearing aids.
- 58% of Payers Use Outcomes-Based Contracts for Prescription Drugs
- In the US, 85-90% of people who have sudden cardiac arrests do not survive. A home defibrillator cost $1,000. (NYT)
- Michael Milken: “We can now reasonably speculate about therapies that will give us the ability to clean tiny cancers from our bodies as routinely as dentists clean our teeth.”
- How Medicaid regulates drug prices.
Thursday Links
- Families making as much as $600,000 can get an Obamacare subsidy. The entire W&M hearing with Sec. Becerra is either very funny or very sad, depending on how the spirit moves you.
- The federal government spent a total of $4.1 trillion on transfer payments to individuals in FY 2022. By comparison, the government spent $2.8 trillion on these programs in 2019.
- Cowen: Would an AI Pause in the US open the door to other countries? What if it stifles the cure for cancer?
- GFPT-4 fails the sophomore econ exam.